The association of medicare drug coverage with use of evidence-based medications in the Veterans Health Administration

Annals of Pharmacotherapy

Volumn 43, Issue 10, 2009, Pages 1565-1575

  Johnson, Michael L ^a,b   Petersen, Laura A ^b,c   Sundaravaradan, Raji ^b   Byrne, Margaret M ^d   Hasche, Jennifer C ^b   Osemene, Nora I ^e   Wei, Iris I ^f   Morgan, Robert O ^b,g  

^a UNIVERSITY OF HOUSTON   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e TEXAS SOUTHERN UNIVERSITY   (United States)

^f CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

^g UNIVERSITY OF TEXAS   (United States)

Author keywords

Managed care; Medicare; Pharmacy; Veterans

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIANGINA PECTORIS AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; EVIDENCE BASED PRACTICE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE MANAGEMENT; HEALTH CARE SYSTEM; HEALTH MAINTENANCE ORGANIZATION; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; MEDICARE; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOCIAL STATUS;

AGED; DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; FEE-FOR-SERVICE PLANS; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HEART FAILURE; HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; LOGISTIC MODELS; MALE; MEDICARE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 70449492016     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L606     Document Type: Article

References (30)

1. Blumenthal D, Herdman R, eds. Descriptions and analysis of the VA national formulary. Institute of Medicine, Division of Health Care Services. Washington, DC: National Academy Press, 2000.
2. Morgan R, Petersen L, Hasche J, et al. VA pharmacy use in veterans with Medicare drug coverage. Am J Manag Care 2009:15:e1-e8.
3. Smith C, Cowan C, Sensenig A, Catlin A. Health Accounts Team. Health spending growth slows in 2003. Health Aff (Millwood) 2005;24: 185-194 Epub 11 Jan 2005.
4. Achman L, Gold M. Out-of-pocket health care expenses for Medicare HMO beneficiaries: estimates by health status, 1999-2001. Publication number 494, The Commonwealth Fund. 2002. www.commonwealthfund. org/Search.aspx?search=achman (accessed 2009 Aug 17).
5. General Accounting Office. VA's management of drugs on its national formulary. Washington, DC: General Accounting Office, 1999.
6. Passman LJ, Garcia RE, Campbell L, Winter E. Elderly veterans receiving care at a Veterans Affairs medical center while enrolled in Medicare-financed HMOs. Is the taxpayer paying twice? J Gen Intern Med 1997;12: 247-249
7. Zhu SC, Gardner JA, West W, Hendricks AM. Do enrollees come to the VA just for pharmacy? Presented at: Department of Veterans Affairs Annual Health Services Research and Development Service Meeting, Washington, DC, 2002.
8. Morgan R. Individual-level factors affecting enrollment in Medicare+ Choice Plans and use of VA medical care by Medicare enrolled white, African American and Hispanic veterans. Technical Report. Included in the Final Project Report for the study, Medicare HMO enrollment and VA use by minority and low-income veterans (VA HSR&D IIR 20-052), 2004.
9. Weeks W, Mahar PJ, Wright SM. Utilization of VA and Medicare services by Medicare-eligible veterans: the impact of additional access points in a rural setting. J Healthcare Manag 2005;50:95-107. (Pubitemid 40397352)
10. Yu W, Ravelo A, Wagner TH, et al. Prevalence and costs of chronic conditions in the VA health care system. Med Care Res Rev 2003;60:146S-67S.
11. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetic prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004;27:B10-21.
12. Landrum MB, Guadagnoli E, Zummo R, Chin D, McNeil BJ. Care following acute myocardial infarction in the VA medical centers: a comparison with Medicare. HSR: Health Serv Res 39:(part 1):1773-1792
13. McCullogh PA, Philbin EF, Spertus TA, Kaatz S, Sanberg KR, Weaver WD. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002;39:60-69 (Pubitemid 34059862)
14. Johnson ML, El-Serag HB, Tran TT, Hartman C, Richardson P, Abraham NS. Adapting the Rx-Risk-V for mortality prediction in outpatient populations. Med Care 2006;44:793-797 (Pubitemid 44284272)
15. Achman L. Gold M. Medicare+Choice 1999-2001: an analysis of managed care plan withdrawals and trends in benefits and premiums. Publication 497. The Commonwealth Fund 2002. www.commonwealthfund. org/Search.aspx?search=achman (accessed 2009 Aug 17)
16. Wei II, Virnig BA, John DA, Morgan RO. Using a Spanish surname match to improve identification of Hispanic women in Medicare administrative data. Health Serv Res 2006;41:1469-1481
17. Morgan RO, Wei I, Virnig BA. Use of surname matching to identify elderly Hispanic males in combined Medicare/VA data files. Med Care 2004;42:810-816
18. Pope GC, Kautter J, Ellis RP, et al. Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev 2004;25:119-141 (Pubitemid 39201560)
19. Petersen LA, Pietz K, Woodard LD, Byrne M. Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes. Med Care 2005;43:61-67 (Pubitemid 40137615)
20. Ashkenazy R, Abrahamson MJ. Medicare coverage for patients with diabetes: a national plan with individual consequences. J Gen Intern Med 2006;21:386-392
21. Epstein BJ, Gums JG. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations. Ann Pharmacother 2005;39:470-480 Epub 8 Feb 2005. DOI 10.1345/aph.1E478
22. Shen Y, Hendricks A, Li D, Gardner J, Kazis L. VA - Medicare dual beneficiaries' enrollment in Medicare HMOs: access to VA, availability of HMOs, and favorable selection. Med Care Res Rev 2005;62:479-495 (Pubitemid 41026293)
23. Department of Veterans Affairs. Administration seeks $70.8 billion for VA in 2006. www1.va.gov/opa/pressrel/PressArtInternet.cfm?id=941 (accessed 2009 Apr 3).
24. West JC, Wilk JE, Muszynski IL, et al. Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first four months of the Medicare prescription drug benefit. Am J Psychiatry 2007; 164: \789-96.
25. Petersen LA, Normand SL, Leape LL, McNeil BJ. Comparison of use of medications after acute myocardial infarction in the Veterans Health Administration and Medicare. Circulation 2001;104:2898-2904
26. Johnson ML, Singh H. Patterns of antihypertensive therapy among patients with diabetes. J Gen Intern Med 2005;20:842-846 (Pubitemid 41725700)
27. Iezzoni LI. Assessing quality using administrative data. Ann Intern Med 1997;127:666-674
28. Black C, Roos NP. Administrative data. Baby or bathwater? Med Care 1998;36:3-5.
29. Austin PC, Tu JV, Ko DT, Alter DA. Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction. CMAJ 2008;179:895-900.
30. Lee DS, Mamdani MM, Austin PC, et al. Trends in heart failure outcomes and pharmacotherapy: 1992-2000. Am J Med 2004;116:581-9.